UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000038683
Receipt number R000044061
Scientific Title Real-world observational study on the efficacy and safety of first-line osimertinib treatment and on post-progression patterns of care in patients with epidermal growth factor receptor activating mutation positive (EGFRm +) advanced non-small-cell lung cancer (NSCLC) -Reiwa-
Date of disclosure of the study information 2019/11/26
Last modified on 2019/11/25 16:01:43

No. Disposal Last modified on Item of update
1 Insert 2019/11/25 16:02:21